ArticleMedical physics2019
Radiomics robustness assessment and classification evaluation: A two-stage method demonstrated on multivendor FFDM.
Article in Medical physics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 30 citations in OpenAlex.
- The role of radiomics in predicting the response to neoadjuvant chemotherapy for breast cancer.Cancer biology & medicine · 2026Review
- Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- Cross-Software Radiomic Feature Robustness Assessed by Hierarchical Clustering and Composite Index Analysis: A Multi-Cancer Study on Colorectal and Liver Lesions.Bioengineering (Basel, Switzerland) · 2025Article
- Quantitative assessment of impact of technical and population-based factors on fairness of AI models for chest X-ray scans.Computers in biology and medicine · 2025Article
- Article
- Radiomics in breast cancer: Current advances and future directions.Cell reports. Medicine · 2024Review
- Worldwide research landscape of artificial intelligence in lung disease: A scientometric study.Heliyon · 2024Article
- Saliency of breast lesions in breast cancer detection using artificial intelligence.Scientific reports · 2023Article
- A Statistical Approach to Assess the Robustness of Radiomics Features in the Discrimination of Mammographic Lesions.Journal of personalized medicine · 2023Article
- Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling.Military Medical Research · 2023Review
- Criteria for the translation of radiomics into clinically useful tests.Nature reviews. Clinical oncology · 2023Review
- Challenges in ensuring the generalizability of image quantitation methods for MRI.Medical physics · 2022Review
- Incorporating Robustness to Imaging Physics into Radiomic Feature Selection for Breast Cancer Risk Estimation.Cancers · 2021Article
- Radiomics as a New Frontier of Imaging for Cancer Prognosis: A Narrative Review.Diagnostics (Basel, Switzerland) · 2021Review
- Article
- Tumor response prediction inEJNMMI physics · 2020Article
- Robust Radiomic Feature Selection in Digital Mammography: Understanding the Effect of Imaging Acquisition Physics Using Phantom and Clinical Data Analysis.Proceedings of SPIE--the International Society for Optical Engineering · 2020Article
- Harmonization of radiomic features of breast lesions across international DCE-MRI datasets.Journal of medical imaging (Bellingham, Wash.) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
purposeRadiomic texture analysis is typically performed on images acquired under specific, homogeneous imaging conditions. These controlled conditions may not be representative of the range of imaging conditions implemented clinically. We aim to develop a two-stage method of radiomic texture analysis that incorporates the reproducibility of individual texture features across imaging conditions to guide the development of texture signatures which are robust across mammography unit vendors.
methodsFull-field digital mammograms were retrospectively collected for women who underwent screening mammography on both a Hologic Lorad Selenia and GE Senographe 2000D system. Radiomic features were calculated on manually placed regions of interest in each image. In stage one (robustness assessment), we identified a set of nonredundant features that were reproducible across the two different vendors. This was achieved through hierarchical clustering and application of robustness metrics. In stage two (classification evaluation), we performed stepwise feature selection and leave-one-out quadratic discriminant analysis (QDA) to construct radiomic signatures. We refer to this two-state method as robustness assessment, classification evaluation (RACE). These radiomic signatures were used to classify the risk of breast cancer through receiver operator characteristic (ROC) analysis, using the area under the ROC curve as a figure of merit in the task of distinguishing between women with and without high-risk factors present. Generalizability was investigated by comparing the classification performance of a feature set on the images from which they were selected (intravendor) to the classification performance on images from the vendor on which it was not selected (intervendor). Intervendor and intravendor performances were also compared to the performance obtained by implementing ComBat, a feature-level harmonization method and to the performance by implementing ComBat followed by RACE.
resultsGeneralizability, defined as the difference between intervendor and intravendor classification performance, was shown to monotonically decrease as the number of clusters used in stage one increased (Mann-Kendall P < 0.001). Intravendor performance was not shown to be statistically different from ComBat harmonization while intervendor performance was significantly higher than ComBat. No significant difference was observed between either of the single methods and the use of ComBat followed by RACE.
conclusionsA two-stage method for robust radiomic signature construction is proposed and demonstrated in the task of breast cancer risk assessment. The proposed method was used to assess generalizability of radiomic texture signatures at varying levels of feature robustness criteria. The results suggest that generalizability of feature sets monotonically decreases as reproducibility of features decreases. This trend suggests that considerations of feature robustness in feature selection methodology could improve classifier generalizability in multifarious full-field digital mammography datasets collected on various vendor units. Additionally, harmonization methods such as ComBat may hold utility in classification schemes and should continue to be investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.